Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel patent CN104418793B reveals a cost-efficient route for Lu-AE-58054 using m-cresol, offering significant supply chain advantages for Alzheimer's drug manufacturers.
Patent CN103408487B details a novel alkaline purification method for Gimeracil ensuring high purity and yield for reliable pharmaceutical intermediates supply chains.
Patent CN110903346B details a cost-effective acid hydrolysis route for high-purity Vancomycin Impurity C, offering significant advantages for pharmaceutical quality control and supply chain stability.
Patent CN112961100B discloses a novel Pd-catalyzed synthesis of chiral indoles with potent HBV inhibitory activity, offering streamlined manufacturing and supply chain advantages.
Patent CN102180914A details a high-yield synthesis of 2-Deoxy-D-Glucose via selective addition. Offers cost reduction in API manufacturing and scalable supply chain solutions.
Advanced dual-solvent recrystallization method achieving >97% purity. Ideal for reliable pharmaceutical intermediate suppliers seeking cost-effective purification.
Patent CN102746207B details a novel Oxiracetam synthesis using silyl protection, offering high purity and yield for reliable pharmaceutical intermediates supply chains.
Patent CN101925589B details a novel palladium-catalyzed process for 4-vinyl-23-dihydrobenzofuran ensuring high purity and scalable manufacturing for global pharmaceutical supply chains.
Patent CN101130503B details a robust synthesis route for L-Serine-15N. Achieves high 15N abundance and purity for reliable supply chain integration.
Patent CN105272908B reveals a high-yield nitration process for Crizotinib intermediates offering substantial cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Patent CN109134402A reveals efficient one-step synthesis technology. Offers significant cost reduction and supply reliability for global pharmaceutical intermediate manufacturing partners.
Patent CN103102357B details a low-toxicity synthesis route for Cefuroxime sodium offering improved yield and stability for pharmaceutical supply chains.
Patent CN1875018A reveals a safer, non-ether solvent reduction method for thiazolidinedione APIs, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN113804805A details a solvent-free method for synthesizing Pregabalin Impurity II. Achieve >99% purity for QC standards with reduced environmental impact.
Optimized synthesis of DOTA-EB-PSMA precursor reduces HPLC steps ensuring high purity and scalable supply for prostate cancer radioligand therapy manufacturing.
Patent CN116396275B reveals a one-pot cyanation strategy for Topiroxostat, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Discover a novel, non-Grignard synthesis for 1-cyclopropyl-2-(2-fluorophenyl) ethyl ketone. Enhanced safety, mild conditions, and scalable manufacturing for antithrombotic APIs.
Patent CN110256261B details a novel copper-coordinated chiral resolution method for high-purity L-2-amino-1-butanol, offering significant supply chain and cost advantages.
Patent CN110656347B details a green electroreduction method for Olanzapine intermediates, eliminating toxic reagents and heavy metals for reliable pharmaceutical supply chains.
Advanced synthesis route for Tenofovir intermediate CN103408547B. Offers cost reduction in API manufacturing and reliable pharmaceutical intermediate supply chain solutions.